DIA 48th Annual Meeting
Click here to go to the previous page
EMRs for Clinical Research: Hype versus Reality - A Management Primer
Track
:
Track 01: Clinical Operations
Program Code:
102
Date:
Monday, June 25, 2012
Time:
10:00 AM to 11:30 AM
EST
CHAIR
:
Edward Seguine, Clinical Ink, United States
PRESENTER
(S):
Dennis Marquis, Bristol-Myers Squibb Company, United States Jonathan Helfgott, FDA, United States Andrew Roberts, Novartis Institutes for BioMedical Research, Switzerland
Description
Electronic medical records (EMRs) are often touted as the miraculous solution to reduce clinical trial costs in the future. This session focuses on the business model implications of using EMRs for clinical research and how that could affect whether EMRs are really the solution.
Learning Objectives:
Differentiate myth from fact about EMRs for clinical research
Summarize major business model implications of proposed EMR-EDC standardization efforts in language executives can understand
Evaluate relevance of EMR data for specific study objectives.
Learning Objectives:
Differentiate myth from fact about EMRs for clinical research
Summarize major business model implications of proposed EMR-EDC standardization efforts in language executives can understand
Evaluate relevance of EMR data for specific study objectives.
This session is a part of:
Handout Online
